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Background: Small airway closure in asthma is determined by a complex interaction of
structural and functional characteristics including lung elastic recoil. Recently, we deter-
mined that loss of elastic recoil might be attributable to pentosidine level in the airways.
This study was designed to investigate the influences of aging and smoking on small airway
closure in asthma.
Methods: Sixty-one patients with asthma (20 non-smoking young adult, 23 non-smoking
elderly, and 18 smoking young adult) and 36 control subjects (12 non-smoking young adult,
11 non-smoking elderly, and 13 smoking young adult) were included. We assessed airway
responses during methacholine provocation and calculated the closing index. In addition,
we measured pentosidine levels in induced sputum from all study subjects.
Results: Pentosidine levels in induced sputum were markedly higher in asthmatic patients
than in controls. In control subjects, the intergroup differences in pentosidine level among
3 subgroups were significant. Similarly, pentosidine levels were significantly higher in non-
smoking elderly and smoking young adult asthmatics than in non-smoking young adult asth-
matics. There was no significant difference in pentosidine levels between non-smoking
elderly and smoking young adult asthmatics. The closing index was also significantly higher
in non-smoking elderly and smoking young adult asthmatics than in non-smoking young
adult asthmatics. Moreover, pentosidine levels in non-smoking elderly and smoking young
adult asthmatics were closely correlated with closing index.nitrogen alveolar plateau; DRS, doseeresponse slope; DTT, dithiothreitol; FEV1, forced expiratory
al capacity; IQR, interquartile range; NO, nitric oxide; PC20 methacholine, provocative concentration
choline.
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710 H. Kanazawa et al.Conclusions: We determined the correlation of pentosidine level with susceptibility to
small airway closure in elderly and smoking asthmatics. Our results might facilitate the un-
derstanding of elderly and smoking asthma.
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Asthma is a chronic inflammatory airway disease charac-
terized by variable airway obstruction attributed to an
underlying inflammatory process and airway remodeling
[1]. In general, the pathophysiology of asthma has been
based on these inflammatory and structural changes
occurring predominantly in the large airways [2]. How-
ever, these histopathologic changes also occur in the
small airways, resulting in functional consequences such
as small airway closure [3]. Increased small airway
closure has been associated with a greater risk of severe
asthma exacerbations and correlated with the severity of
asthma [4]. Small airway closure in asthma is determined
by a complex interaction of structural and functional
characteristics including the thickness and elastic prop-
erties of the airway wall [5]. Several studies have
determined that reduced elastic recoil is primarily
responsible for small airway closure in asthma [6e8].
These findings indicate that the relative contribution of
reduced elastic recoil to small airway closure is of high
importance [9]. Interestingly, reduced elastic recoil has
been observed in stable, asymptomatic asthmatic pa-
tients as well as in patients with severe exacerbations of
the disease. Moreover, it is also reported that even
asthmatic patients with no actual airway obstruction
have reduced elastic recoil [10].
Pentosidine is well established as an intermolecular
cross-linking type of advanced glycation end products, and
it accumulates with aging in various connective tissues
including collagen [11e14]. It is formed through a series of
non-enzymatic reactions between glucose and proteins
resulting in a highly stable cross-linked product. One of
the contributing factors to its production is oxidative
stress. Although all proteins are prone to pentosidine
formation, deleterious pentosidine accumulation occurs in
tissues with low turnover, including collagen. This accu-
mulation subtly alters collagen structure and function,
increasing stiffness in arteries, skin, bone, and lung
[15,16]. In human studies, pentosidine has also been found
to be responsible for collagen cross-linking in lung tissues
[17]. Recently, we demonstrated that pentosidine levels in
induced sputum were significantly higher in asthmatic
patients than in normal controls, and that loss of elastic
recoil might be attributable to pentosidine level in the
airways [18].
An aging population will result in increased prevalence
of elderly asthma; therefore, it is important to clarify the
pathophysiological features of this condition. To date, dif-
ficulties have been encountered in differentiating asthma
and COPD [19]. Cigarette smoking is a major diagnostic
confounder in elderly populations, and published de-
scriptions of elderly asthma are derived from cohorts thatinclude smokers [20]. Because of the confounding effects of
smoking, these descriptions might not truly reflect elderly
asthma. A previous study reported that small airway closure
in elderly asthmatics was increased compared with younger
asthmatics [7]. Although age-related loss of elastic recoil is
likely the main cause of this phenomenon, the precise
mechanism remains undetermined. In order for a popula-
tion of elderly asthmatic patients to serve as a model in
which to examine small airway closure, the confounding
effects of smoking must be eliminated. Therefore, this
study was designed to investigate the influences of aging
and smoking on susceptibility to small airway closure in
asthma.
Methods
Study subjects
Sixty-one patients with asthma (20 non-smoking young
adult, 23 non-smoking elderly, and 18 smoking young
adult) and thirty-six control subjects (12 non-smoking
young adult, 11 non-smoking elderly, and 13 smoking
young adult) were included in this study. Young adult
subjects were aged 20e40 years, and elderly subjects
were more than 60 years of age. Smokers were aged 20e40
years, and had more than a 10 pack-year history (control
smokers, range: 10e19 pack-years; asthmatic smokers:
10e21 pack-years). All control subjects were volunteers
who had no history of lung diseases. All asthmatic patients
had been newly diagnosed with asthma at the respiratory
outpatient clinics of our university hospital on entry into
this study. All asthmatics had: (1) episodic cough, wheeze
and dyspnea; (2) normal chest roentgenograph; (3)
reduction of forced expiratory volume in 1 s (FEV1) in case
of asthma attack and increase of 20% or greater in FEV1 in
response to a bronchodilator; (4) airway hyper-
responsiveness to methacholine. In addition, all of them
were atopy; total serum immunoglobulin E (IgE) levels
were more than 250 IU/mL, and one or more common
aeroallergens were determined by specific IgE. At the time
of the study, all asthmatic patients were solely receiving
salbutamol for as-needed relief of symptoms without
controller medications (i.e., long-acting b2-agonists,
leukotriene modifiers, and oral or inhaled corticosteroids).
Exhaled nitric oxide (NO) levels were measured with a
chemiluminescence analyzer with a resolution of 1 parts
per billion (ppb) in accordance with the American Thoracic
Society standards [21]. All asthmatic patients were clini-
cally stable, and none had a history of respiratory infec-
tion for at least the 4-week period preceding the study. All
subjects provided written informed consent for partici-
pation in the study, which was approved by the Ethics
Committee of Osaka City University.
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All study subjects underwent pulmonary function tests just
before sputum induction, by using a CHESTAC-8800 unit
(Chest, Tokyo, Japan) according to the recommendations of
the American Thoracic Society/European Respiratory Soci-
ety [22,23]. Forced vital capacity (FVC) and FEV1 were
determined. The best of 3 consecutive attempts in spiro-
metric measurements was recorded.
Methacholine provocation test
The methacholine provocation test was performed in all
study subjects. The test was performed as we previously
described [24]. The provocative concentration causing a
20% fall in FEV1 with methacholine (PC20 methacholine)
was calculated by interpolating between 2 adjacent data
points when the FEV1 decreased by >20%. Spirometric
measurements of FEV1 and FVC were made after each
concentration step of methacholine challenge, with FVC
maneuvers continued for a minimum of 6 s and until a clean
plateau in the expiratory volume trace was observed. FEV1
is a global measure of lung function so that reductions in
FEV1 during methacholine challenge reflect changes both in
airway narrowing and airway closure. By contrast, FVC is
determined solely by the volume of expiratory air, and this
volume is reduced by airway closure but not by airway
narrowing. In this study, we used the closing index (% fall in
FVC/% fall in FEV1) as an index of airway closure [5]. We
calculated the closing index to determine the effect on FVC
at a given degree of bronchoconstriction and assessed the
degree of airway closure. In addition, the doseeresponse
slope (DRS) was also calculated as the two point slope from
the % fall in FEV1 or FVC at the end of methacholine chal-
lenge divided by the dose in micromoles. Thus, sensitivity
to airway narrowing (DRS[FEV1]) and sensitivity to airway
closure (DRS[FVC]) was assessed respectively.
Sputum induction and processing
Sputum induction was performed as we previously
described [25]. The slides were prepared using a cytospin
(Cytospin 3: Shandon, Tokyo, Japan) and stained with May-
GrunwaldeGiemsa stain for eosinophil counts. Pentosidine
levels in sputum samples were measured using commercial
enzyme-linked immunosorbent assay kits (Fushimi Phar-
maceutical Co., Marugame, Japan). Preliminarily, we
examined the reproducibility and found no detrimental
effects of dithiothreitol (final concentration of 1 mM)
(WAKO Pure Chemical Industries Ltd, Osaka, Japan) on
measurement of pentosidine levels in induced sputum. In
this assay system, the limit of detection for pentosidine was
0.5 ng/mL.
Statistical analysis
All data are presented as median and interquartile range
[IQR]. When multiple comparisons of non-parametric data
were performed between groups, significant intergroup
variability was first established using the KruskaleWallis
test. The ManneWhitney U test was then used forintergroup comparisons. The significance of correlation was
evaluated by determining Spearman’s rank correlation co-
efficients. A p-value <0.05 was considered significant.
Results
Clinical characteristics of study subjects
The clinical characteristics of 61 patients with asthma and
36 control subjects are shown in Table 1. Compared with
control subjects, asthmatic patients showed greater airway
obstruction. Furthermore, the percentage of eosinophils in
induced sputum and exhaled NO level were also signifi-
cantly higher in asthmatic patients than in controls. No
significant differences in baseline lung function and sputum
eosinophils could be observed among 3 subgroups of asth-
matic patients.
Pentosidine levels in control subjects and
asthmatic patients
Pentosidine levels in induced sputum were markedly higher
in asthmatic patients than in controls (asthmatics: 23.9
[18.6e29.8] ng/mL; controls: 3.3 [1.6e9.4] ng/mL;
p < 0.001). In control subjects, the intergroup differences
in pentosidine level among 3 subgroups were significant
(non-smoking young adult: 1.9 [0.8e3.0] ng/mL; non-
smoking elderly: 9.6 [6.7e10.2] ng/mL; smoking young
adult: 5.3 [3.8e6.2] ng/mL) (Fig. 1). Pentosidine levels in
non-smoking elderly and smoking young adult controls were
significantly higher than those in non-smoking young adult
controls. Similarly, the intergroup differences in pentosi-
dine level among 3 subgroups of asthmatics were also sig-
nificant (non-smoking young adult: 16.5 [15.2e18.3] ng/
mL; non-smoking elderly: 27.3 [22.8e34.4] ng/mL; smoking
young adult: 26.8 [25.4e30.3] ng/mL). There was no sig-
nificant difference between non-smoking elderly and
smoking young adult asthmatics. In contrast, pentosidine
levels in non-smoking elderly and smoking young adult
asthmatics were significantly higher than in non-smoking
young adult asthmatics.
Airway closure in control subjects and asthmatic
patients
All asthmatic patients had airway hyperresponsiveness to
methacholine (PC20 methacholine <8 mg/mL) (Table 2).
PC20 methacholine showed similar levels among 3 sub-
groups of asthmatics. Maximum changes in FEV1 and FVC
after methacholine provocation were also similar among 3
subgroups of asthmatics. Both sensitivity to airway nar-
rowing (DRS[FEV1]) and sensitivity to airway closure (DRS
[FVC]) were significantly higher in asthmatic patients than
in controls. DRS[FEV1] did not differ significantly among 3
subgroups of controls and asthmatic patients. Although DRS
[FVC] was similar in 3 subgroups of controls, the non-
smoking elderly and smoking young adult asthmatics
showed significantly higher levels than non-smoking young
adult asthmatics. However, there was no significant dif-
ference in DRS[FVC] between non-smoking elderly and
Table 1 Clinical characteristics of study subjects.
Control subjects Asthmatic patients
Young adult
smoking ()
(20e40 years)
Elderly
smoking ()
(>60 years)
Young adult
smoking (þ)
(20e40 years)
Young adult
smoking
() (20e40 years)
Elderly smoking
() (>60 years)
Young adult
smoking (þ)
(20e40 years)
Subject No. (M/F) 12 (5/7) 11 (3/8) 13 (10/3) 20 (8/12) 23 (11/12) 18 (14/4)
Age (years) 30 [23e32] 72 [66e74] 32 [31e37] 33 [30e36] 67 [63e68] 35 [32e37]
FEV1 (%predicted) 105 [99e116] 98 [92e104] 94 [90e100]
a 72 [69e81] 74 [67e78] 73 [68e79]
FEV1/FVC (%) 88 [81e90] 81 [78e88]
a 75 [72e80]a,b 71 [65e75] 65 [63e70] 68 [62e74]
Exhaled NO (ppb) 22 [20e23] 20 [19e22] 17 [16e18]a,b 37 [34e40] 36 [31e40] 33 [32e37]c
Sputum eosinophils (%) 0.1 [0e0.3] 0.2 [0e0.3] 0.1 [0e0.2] 8.2 [6.5e10.5] 7.1 [5.5e9.3] 7.1 [3.9e10.8]
Definition of abbreviations: FEV1 Z forced expiratory volume in one second; FVC Z forced vital capacity; NO Z nitric oxide.
All values are median [ICR].
a p<0.01 compared with non-smoking young adult controls.
b p < 0.01 compared with non-smoking elderly controls.
c p < 0.05 compared with non-smoking young adult asthmatics.
712 H. Kanazawa et al.smoking young adult asthmatics. We ascertained that there
was a linear relationship between the changes in FEV1 and
FVC throughout the methacholine challenge in all study
subjects. This strong linear relationship between changes in
FEV1 and FVC implies that the contribution of airway
closure to the change in FEV1 was consistent over the range
of airway responses observed in the methacholine chal-
lenge test. In asthmatic patients, the linear relationship
between the changes in FEV1 and FVC (the ratio of % change
in FVC to % change in FEV1; closing index) was significantly
higher in non-smoking elderly and smoking young adult
asthmatics than in non-smoking young adult asthmatics.
However, the closing index in non-smoking elderly asth-
matics did not differ from that in smoking young adult
asthmatics. In non-smoking elderly asthmatics, pentosidine
level was closely correlated with closing index (r Z 0.75,
p Z 0.001) (Fig. 2). Similar result was revealed in smoking
young adult asthmatics (r Z 0.74, p Z 0.003) (Fig. 3).Figure 1 Comparisons of pentosidine levels in induced
sputum from normal controls and asthmatic patients each bar
represents the median value.However, pentosidine level was not significantly correlated
with closing index in non-smoking young asthmatics and 3
subgroups of control subjects. In addition, the actual levels
of airway inflammation (% eosinophils in induced sputum
and exhaled NO levels) were also not significantly corre-
lated with closing index.
Discussion
Increased small airway closure in asthma may lead to a
mechanical disadvantage and contribute to dyspnea and
limitations of physical activity. From this viewpoint, small
airway closure is a clinically important profile of the disease
severity. However, small airway closure is difficult to
measure directly and, therefore, has been estimated indi-
rectly using a range of physiological techniques. We also
assessed spirometric parameters during methacholine
provocation as simple surrogate measures of small airway
closure. Using this method, we could evaluate the extent of
airway narrowing and airway closure separately, and rep-
resented the extent of small airway closure as the closing
index. To date, it is not clear whether the extent of small
airway closure differs between asthmatic and non-
asthmatic subjects. Using radionuclide imaging, King
et al. found no difference in the extent of small airway
closure between asthmatic and non-asthmatic subjects
[26]. In this study, we also found that closing index was
similar in asthmatic and non-asthmatic subjects of aged
20e40 years.
Smokers with asthma have poorly controlled symptoms,
impaired therapeutic responses to corticosteroids, and
increased rates of health care utilization compared with
non-smokers with asthma [27]. In this study, we found
that smoking itself is an essential causal factor for
increased small airway closure in asthmatic subjects. The
effects of smoking might contribute to the accelerated
loss of lung elastic recoil, resulting in an increased ten-
dency to small airway closure. Elderly asthma is often
assumed to include 2 subgroups: those who have had
asthma from childhood (long-standing asthma) and those
who develop asthma in old age (late-onset asthma).
Because we included only the latter in this study, it was
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Figure 2 Correlation between pentosidine level in induced
sputum and closing index in elderly asthmatic patients.
Role of pentosidine on small airway closure 713not necessary to consider the effects of asthma duration
on small airway closure. In normal aging, there are age-
related structural changes in the respiratory system.
With increased age, elastic fibers in the lung parenchyma
decrease, and alter the elastic properties of the airways.
Thus, aging itself has been associated with loss of elastic
recoil, resulting in mechanical disruption [28]. However,
the former hypothesis is that elastic recoil is lost with
ageing because of changes in the spatial arrangement
and/or crosslinking of the elastic fiber network or because
of the presence of a pseudoelastin [29]. The major lung
extracellular matrix components are collagens, elastic fi-
bers, proteoglycans, fibronectin and tenascin. Collagen
and elastin are the main proteins in the extracellular
matrix that make up the framework of the lung paren-
chyma and most important in determining the mechanical
properties [30]. In particular, collagen is the most abun-
dant component. Therefore, it is plausible that the
abnormal cross-linking of collagen mediated by pentosi-
dine might contribute to lung elastic recoil. Elderly
asthma is supposed to prominently involve small airway
closure [31]. Milanese et al. previously found that small
airway closure exists in older asthmatics compared with
younger asthmatics [32]. In this study, we also found that
aging is a causal factor for increased small airway closure
in asthmatic subjects. These findings suggest that elderly
asthma may have an increased small airway closure via
age-related loss of elastic recoil. Thus, smoking and
elderly asthmatics had markedly accelerated the suscep-
tibility to small airway closure compared with younger and
non-smoking asthmatics.
The precise mechanism of increased small airway
closure in smokers and elderly subjects with asthma is
uncertain. In particular, there is no clear consensus as to
what constitutes small airway closure in asthmatic pa-
tients. It is plausible that multiple mechanisms may lead
to small airway closure in elderly and smoking asthmatics.
We demonstrated for the first time that pentosidine levels
were significantly higher in smoking young adult controls
compared with non-smoking young adult controls, and
that those levels were further increased in smoking young
adult asthmatics. Similarly, pentosidine levels were
significantly higher in non-smoking elderly asthmatics
Figure 3 Correlation between pentosidine level in induced
sputum and closing index in smoking asthmatic patients.
714 H. Kanazawa et al.than in non-smoking elderly non-asthmatics. A noteworthy
finding is that pentosidine levels in smoking young adult
and non-smoking elderly asthmatics were closely corre-
lated with closing index. Pentosidine levels in non-
smoking elderly and smoking young adult controls were
significantly higher than those in non-smoking young adult
controls. However, Its levels in elderly and smoking con-
trols were considerable low compared to 3 subgroups of
asthmatic patients. It is supposed that pentosidine levels
above a certain threshold might be required to affect
closing index. Moreover, we did not find the significant
correlation between pentosidine level and % eosinophils in
induced sputum or exhaled NO level in 3 subgroups of
asthmatic patients. Thus, long-term pentosidine accumu-
lation in the airways was not significantly correlated with
the severity of current airway inflammation. On the basis
of these findings, the present study clearly showed that
the susceptibility to small airway closure is associated
with airway pentosidine level. We previously found an
increase in the slope of the nitrogen alveolar plateau
(delta N2) with aging, and that values of delta N2 in each
age range were significantly higher in asthmatics than in
normal controls [33]. Moreover, pentosidine level was
closely correlated with delta N2 value in asthmatic pa-
tients. These findings suggest that high levels of pentosi-
dine may be associated with small airway closure or near
closure. The aging lung may undergo prominent changes in
structure and function, including loss of elastic recoil.
Because elastic recoil may be a limiting factor in
increased small airway closure during bronchocon-
striction, age- and smoking-related loss in elastic recoil
may result in increased small airway closure.
The present study has several limitations. First, this
study revealed an association between pentosidine level
and extent of small airway closure, but did not investigate
the causality of this association. Longitudinal studies will
be required to determine direct causal relationships be-
tween these factors. Moreover, it is also important to know
the relationship between airway remodeling and pentosi-
dine accumulation in the airways. Second, we estimated
the extent of small airway closure by using only spirometry.
The results should be assessed using other techniques such
as nitrogen washout and radionuclide imaging.In summary, we revealed a significant association be-
tween airway pentosidine level and small airway closure in
elderly and smoking asthmatics, and suggest that increased
airway pentosidine levels evoked by smoking and aging may
lead to small airway closure associated with loss of lung
elastic recoil. These findings suggest that aging and smoking
may independently accelerate the susceptibility to small
airway closure in asthmatic subjects. Our results will
encourage more studies to assess the relationship between
airway pentosidine level and mechanical airway properties
in smoking and elderly asthmatics. This study will provide
new insights into small airway closure in asthma, and may
be of great use in understanding the pathogenesis of elderly
and smoking asthma.Funding
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